We are glad to announce that we are nominated for Prix Galien MedStartup in the category “Pharmaceutical and Biotechnology” ! This prize, by the prestigious Galien Foundation and Business France, rewards the best Franco-American collaboration in the biopharmaceutical industry. We are nominated for our collaboration with the Harvard Stem Cell Institute and the Dana Farber Cancer Institute in Boston USA,  the Foundation for Biomedical Research and Innovation in Kobe, Japan, and the Imagine Institute in Paris, France. This research consortium, entitled QC-Stem, brings together world-class experts to study the quality of induced pluripotent stem cells (iPSCs) grown with the 3D C-Stem technology.

Results will be announced on October 26th !